Hamied, (73) however, will continue to be the vice-chairman of the company in a non-executive role effective April 1.
"The board unanimously acknowledges the contribution of M K Hamied to the company over the past 30 years, and in deference to his wishes, has accepted his proposal to retire as Executive Vice-Chairman effective March 31,"
Three Indians who REVOLUTIONISED medicines
SBICAP sells Kingfisher shares worth over Rs 4.52 cr
Rupee drops the most in 2 weeks
Mapping the AAP shock win in New Delhi
The 30 HIGHEST paid CEOs in India